1Le Roith D. Tumor-induced hypoglycemia.N Engl J Med,1999,341(10): 757-758.
2Matsuda S, Usui M, Sakurai H, et al. Insulin-like growth factor Ⅱ-producing intraabdominal hemangiopericytoma associated with hypoglycemia. J Gastroenterol, 2001,36(12): 851-855.
3van Doorn J, Hoogerbrugge CM, Koster JG, et al. Antibodies directed against the E region of pro-insulin-like growth factor-Ⅱ used to evaluate non-islet cell tumor-induced hypoglycemia. Clin Chem, 2002, 48(10): 1739-1750.
4Chung J, Henry RR. Mechanisms of tumorinduced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab,1996,81(3): 919-925.
5Eastman RC, Carson RE, Orloff DC, et al.Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest,1992,89(6) : 1958-1963.
6Furrer J, Hattenschwiler A, Komminoth P,et al. Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver. J Clin Endocrinol Metab,2001,86(5) : 2227-2230.
7Seckl MJ, Mulholland PJ, Bishop AE, et al. Hypoglycemia due to an insulin-secre ting small-cell carcinoma of the cervix. N Engl J Med,1999,341(10): 733-736.
8Teale JD, Wark G. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. Clin Endocrinol(Oxf),2004,60(4): 457-460.
9Gullo D, Sciacca L, Parrinello G, et al.Treatment of hemangiopericytoma-induced hypoglycemia with growth hormone and corticosteroids. J Clin Endocrinol Metab,1999,84(5): 1758-1759.